Compass and ATAI latest news + are Psychedelics BACK in 2025?!

https://is1-ssl.mzstatic.com/image/thumb/Podcasts221/v4/ab/08/66/ab08667b-376d-4202-d812-c044efc84a4f/mza_15113347964605507548.jpg/600x600bb.jpg

Human 3 with Brom and Sam

Brom Rector and Sam Tabone

32 episodes

2 days ago

Interviews with the scientists, founders and investors driving Human 3 - the next epoch of health, wellbeing and performance. Topics include brain-computer interfaces, genetic medicine, psychedelics, longevity, AI and more. Hosted by Brom Rector and Sam Tabone - founders of XEIA Venture Partners, a venture capital fund investing in Human 3. More at www.xeiavp.com

Technology

RSS

All content for Human 3 with Brom and Sam is the property of Brom Rector and Sam Tabone and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

Technology

https://d3t3ozftmdmh3i.cloudfront.net/staging/podcast_uploaded_episode/13191439/13191439-1753766808995-fff2f63657e38.jpg

Compass and ATAI latest news + are Psychedelics BACK in 2025?!

Human 3 with Brom and Sam

16 minutes 7 seconds

3 months ago

Compass and ATAI latest news + are Psychedelics BACK in 2025?!

The past few years have been rough for psychedelic and shroom stocks, but recent news from ATAI (and Recognify), Compass Pathways and GH Research + positive regulatory tailwinds from RFK and MAHA make me think that Psychedelics are back on the menu in 2025.

In this video I discuss:

(0:00) - why psychedelics are hot again in 2025

(5:45) - latest thoughts on Compass a month after their Phase 3 topline data

(9:45) - thoughts on ATAI / Recognify, and how this feeds back into our psychedelic macro theme

Join our investing in psychedelics webinar www.psybio.org